The pyrH gene of Vibrio vulnificus is an essential in vivo survival factor

Infection and Immunity

Volumn 75, Issue 6, 2007, Pages 2795-2801

  Shee, Eun Lee ^a   Soo, Young Kim ^a   Choon, Mee Kim ^a,c   Kim, Mi Kwang ^a   Young, Ran Kim ^a,d   Jeong, Kwangjoon ^a   Ryu, Hwa Ja ^a   Youn, Suhk Lee ^a   Sun, Sik Chung ^a   Choy, Hyon E ^a   Joon, Haeng Rhee ^a,b  

^a Chonnam National University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Chosun University College of Medicine   (South Korea)

^d Dongshin University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARTIC ACID; PHOSPHOTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES FLUID; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; CELL LYSATE; CONTROLLED STUDY; CYTOTOXICITY; DELETION MUTANT; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE INSERTION; GENE MUTATION; GENETIC COMPLEMENTATION; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; IRON OVERLOAD; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PYRH GENE; SITE DIRECTED MUTAGENESIS; SURVIVAL; VIBRIO VULNIFICUS; WILD TYPE;

ANIMALS; ANTIGENS, BACTERIAL; ESCHERICHIA COLI PROTEINS; GENES, SUPPRESSOR; HUMANS; MICE; TRANSFERASES; VIBRIO INFECTIONS; VIBRIO VULNIFICUS;

EID: 34249876230     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01499-06     Document Type: Article

References (38)

1. Brennt, C. E., A. C. Wright, S. K. Dutta, and J. G. Morris, Jr. 1991. Growth of Vibrio vulnificus serum from alcoholics: association with high transferring iron saturation. J. Infect. Dis. 164:1030-1032.
2. Briozzo, P., C. Evrin, P. Meyer, L. Assairi, N. Joly, O. Barzu, and A. M. Gilles. 2005. Structure of Escherichia coli UMP kinase differs from that of other nucleoside monophosphate kinases and sheds new light on enzyme regulation. J. Biol. Chem. 280:25533-25540.
3. Bucurenci. N., L. Serina, C. Zaharia, S. Landais, A. Danchin, and O. Barzu. 1998. Mutational analysis of UMP kinase from Escherichia coli. J. Bacteriol. 180:473-477.
4. Bullen, J. J., P. B. Spalding, C. G. Ward, and J. M. Gutteridge. 1991. Hemochromatosis, iron and septicemia caused by Vibrio vulnificus. Arch. Intern. Med. 151:1606-1609.
5. Curtiss, R., III. 2002. Bacterial infectious disease control by vaccine development. J. Clin. Investig. 110:1061-1066.
6. Devi, S. J., U. Hayat, J. L. Powell, and J. G. Morris, Jr. 1996. Preclinical immunoprophylactic and immunotherapeutic efficacy of antisera to capsular polysaccharide-tetanus toxoid conjugate vaccines of Vibrio vulnificus. Infect. Immun. 64:2220-2224.
7. Ditta, G., D. C. Stanfield, and D. R. Helinski. 1980. Broad host range DNA cloning system for gram-negative bacteria: construction of a gene bank of Rhizobium meliloti. Proc. Natl. Acad. Sci. USA 77:7347-7351.
8. Fields, P. I., R. V. Swanson, C. G. Haidaris, and F. Heffron. 1986. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc. Natl. Acad. Sci. USA 83:5189-5193.
9. Gagyi, C., N. Bucurenci, O. Sirbu, G. Labesse, M. Ionescu, A. Ofiteru, L. Assairi, S. Landais, A. Danchin, O. Barzu, and A. M. Gilles. 2003. UMP kinase from the gram-positive bacterium Bacillus subtilis is strongly dependent on GTP for optimal activity. Eur. J. Biochem. 270:3196-3204.
10. Gulig, P. A., K. L. Bourdage, and A. M. Starks. 2005. Molecular Pathogenesis of Vibrio vulnificus. J. Microbiol. 43:118-131.
11. Heithoff, D. M., C. P. Conner, P. C. Hanna, S. M. Julio, U. Hentschel, and M. J. Mahan. 1997. Bacterial infection as assessed by in vivo gene expression. Proc. Natl. Acad. Sci. USA 94:934-939.
12. Heithoff, D. M., C. P. Conner, and M. J. Mahan. 1997. Dissecting the biology of a pathogen during infection. Trends Microbiol. 5:509-513.
13. Hor, L. I., T. T. Chang, and S. T. Wang. 1999. Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: association with phagocytosis by neutrophils and serum ferritin levels. J. Infect. Dis. 179:275-278.
14. Kang, H. Y., J. Srinivasan, and R. Curtiss III. 2002. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect. Immun. 70:1739-1749.
15. Kholti, A., D. Charlier, D. Gigot, N. Huysveld, M. Roovers, and N. Glansdorff. 1998. pyrH-encoded UMP-kinase directly participates in pyrimidine-specific modulation of promoter activity in Escherichia coli. J. Mol. Biol. 280:571-582.
16. Kim, S. Y., S. E. Lee, Y. R. Kim, C. M. Kim, P. Y. Ryu, H. E. Choy, S. S. Chung, and J. H. Rhee. 2003. Regulation of Vibrio vulnificus virulence by the LuxS quorum-sensing system. Mol. Microbiol. 48:1647-1664.
17. Kim, Y. R., S. E. Lee, C. M. Kim, S. Y. Kim, E. K. Shin, D. H. Shin, S. S. Chung, H. E. Choy, A. Progulske-Fox, J. D. Hillman, M. Handfield, and J. H. Rhee. 2003. Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients. Infect. Immun. 71:5461-5471.
18. Klarsfeld, A. D., P. L. Goossens, and P. Cossart. 1994. Five Listeria mono cytogenes genes preferentially expressed in infected mammalian cells: plcA, purH, purD, pyrE, and an arginine ABC transporter gene, arpJ. Mol. Microbiol. 13:585-597.
19. Kraffert, C. A., and D. J. Hogan. 1992. Vibrio vulnificus infection and iron overload. J. Am. Acad. Dermatol. 26:140.
20. Labesse, G., N. Bucurenci, D. Douguet, H. Sakamoto, S. Landais, C. Gagyi, A. M. Gilles, and O. Barzu. 2002. Comparative modeling and immunochemical reactivity of Escherichia coli UMP kinase. Biochem. Biophys. Res. Commun. 294:173-179.
21. Lee, S. E., S. H. Shin, S. Y. Kim, Y. R. Kim, D. H. Shin, S. S. Chung, Z. H. Lee, J. Y. Lee, K. C. Jeong, S. H. Choi, and J. H. Rhee. 2000. Vibrio vulnificus has the transmembrane transcription activator ToxRS stimulating the expression of the hemolysin gene vvhA. J. Bacteriol. 182:3405-3415.
22. Linkous, D. A., and J. D. Oliver. 1999. Pathogenesis of Vibrio vulnificus. FEMS Microbiol. Lett. 174:207-214.
23. Mahan, M. J., J. M. Slauch, and J. J. Mekalanos. 1993. Selection of bacterial virulence genes that are specifically induced in host tissues. Science 259:686-688.
24. Marco-Marin, C., F. Gil-Ortiz, and V. Rubio. 2005. The crystal structure of Pyrococcus furiosus UMP kinase provides insight into catalysis and regulation in microbial pyrimidine nucleotide biosynthesis. J. Mol. Biol. 352:438-454.
25. Milton, D. L., R. O'Toole, P. Horstedt, and H. Wolf-Watz. 1996. Flagellin A is essential for the virulence of Vibrio anguillarum. J. Bacteriol. 178:1310-1319.
26. Neuhard, J., and R. A. Kelln. 1996. Biosynthesis and conversion of pyrimidines, p. 580-599. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. American Society for Microbiology, Washington, DC.
27. Park, S. D., H. S. Shon, and N. J. Joh. 1991. Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients. J. Am. Acad. Dermatol. 24:397-403.
28. Reddy, G. P., U. Hayat, C. Abeygunawardana, C. Fox, A. C. Wright, D. R. Maneval, Jr., C. A. Bush, and J. G. Morris, Jr. 1992. Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus MO6-24. J. Bacteriol. 174:2620-2630.
29. Reed, L. J., and H. Muench. 1938. A simple method of estimating the fifty percent end points. Am. J. Hyg. 27:493-497.
30. Sakamoto, H., S. Landais, C. Evrin, C. Laurent-Winter, O. Barzu, and R. A. Kelln. 2004. Structure-function relationships of UMP kinases from pyrH mutants of gram-negative bacteria. Microbiology 150:2153- 2159.
31. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
32. Shinoda, S., M. Kobayashi, H. Yamada, S. Yoshida, M. Ogawa, and Y. Mizuguchi. 1987. Inhibitory effect of capsular antigen of Vibrio vulnificus on bactericidal activity of human serum. Microbiol. Immunol. 31:393-401.
33. Simon, R., R. Priefer, and A. Puhler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram-negative bacteria. Biotechnology 1:784-791.
34. Staskawicz, B., D. Dahlbeck, N. Keen, and C. Napoli. 1987. Molecular characterization of cloned avirulence genes from race 0 and race 1 of Pseudomonas syringae pv. glyxinea. J. Bacteriol. 169:5789-5794.
35. Strom, M. S., and R. N. Paranjpye. 2000. Epidemiology and pathogenesis of Vibrio vulnificus. Microbes Infect. 2:177-188.
36. Tacket, C. O., F. Brenner, and P. A. Blake. 1984. Clinical features and an epidemiological study of Vibrio vulnificus infections. J. Infect. Dis. 149:558-561.
37. Ventura, C. L., R. T. Cartee, W. T. Forsee, and J. Yother. 2006. Control of capsular polysaccharide chain length by UDP-sugar substrate concentrations in Streptococcus pneumoniae. Mol. Microbiol. 61:723-733.
38. Wright, A. C., L. M. Simpson, and J. D. Oliver. 1981. Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect. Immun. 34:503-507.